+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 180 Pages
  • Global
From
From
From
From
From
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2024 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
From
From
From
From
Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 240 Pages
  • Global
From
Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 240 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 240 Pages
  • Global
From
From
From
Untreated Metastatic or Unresectable Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Untreated Metastatic or Unresectable Melanoma - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
IPSC derived NK cells - Pipeline Insight, 2024 - Product Thumbnail Image

IPSC derived NK cells - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
Biliary Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more